Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4068 results

Sort By:

Reducing Systemic Inflammation in People on Antiretroviral Therapy

Study ID: NCT07030920
Start Date: 2025-10
End Date: 2029-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

Fostemsavir

Sponsor

University of Montreal Hospital Center (CHUM)

Source: clinicaltrials.gov

Share:
Add to list

Pilot Study of Health System/Community Partnership for Enhanced Outreach to Prevent Suicide Attempts

Study ID: NCT05825820
Start Date: 2025-12
End Date: 2026-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Enhanced Outreach Intervention (EOI) plus Care as Usual

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

International Observatory of Antiphospholipids Treated by Direct Oral Anticoagulants

Study ID: NCT06929182
Start Date: 2025-07-01
End Date: 2035-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

"non-high risk" thrombotic APS patients treated with DOAC

Sponsor

Central Hospital, Nancy, France

Source: clinicaltrials.gov

Share:
Add to list

ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing

Study ID: NCT03767231
Start Date: 2025-11
End Date: 2027-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Xpert HCV Veral Load Finger-Stick Point-of-Care Test (CSPHIDE)

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Study ID: NCT06918431
Start Date: 2025-09-26
End Date: 2028-04-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

53

Intervention / Treatment

Asparaginase Erwinia chrysanthemi

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Cyclophosphamide

Cytarabine

Cytarabine

Daunorubicin Hydrochloride

Dexamethasone

Echocardiography

Lumbar Puncture

Mercaptopurine

Methotrexate

Positron Emission Tomography

Rituximab

Vincristine Sulfate

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in P53-Mutated Endometrial Cancer: a Non-Inferiority Randomized Trial

Study ID: NCT06900582
Start Date: 2025-10
End Date: 2031-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

374

Intervention / Treatment

Sentinel Lymph Node Mapping

Comprehensive pelvic and para-aortic lymphadenectomy

Sponsor

University Hospital, Strasbourg, France

Source: clinicaltrials.gov

Share:
Add to list

Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization

Study ID: NCT06925776
Start Date: 2025-06-30
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

106

Intervention / Treatment

CHOOSE Home Intervention

Usual Care

Sponsor

Montefiore Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Effect of Dry Cupping Therapy Associated With the McKenzie Method in Patients With Chronic Low Back Pain

Study ID: NCT05459376
Start Date: 2026-01-01
End Date: 2028-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Exercises and dry cupping

Sponsor

Federal University of Rio Grande do Norte

Source: clinicaltrials.gov

Share:
Add to list

Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry

Study ID: NCT06992076
Start Date: 2026-02-01
End Date: 2028-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Marstacimab

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Source: clinicaltrials.gov

Share:
Add to list

Validation of the "ExSpiron©" in Patients With ALS

Study ID: NCT04089696
Start Date: 2025-09
End Date: 2025-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

ExSprion

Sponsor

University Medical Center Groningen

Source: clinicaltrials.gov

Share:
Add to list